SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-002600
Filing Date
2013-03-12
Accepted
2013-03-12 16:11:40
Documents
6
Period of Report
2013-04-23
Effectiveness Date
2013-03-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2213443zdef14a.htm DEF 14A 593151
2 G817752.JPG g817752.jpg GRAPHIC 6750
3 G979546.JPG g979546.jpg GRAPHIC 3974
4 G352051.JPG g352051.jpg GRAPHIC 6598
5 G15332CAI001.GIF g15332cai001.gif GRAPHIC 44142
6 G15332CAI002.GIF g15332cai002.gif GRAPHIC 113794
  Complete submission text file 0001047469-13-002600.txt   836461
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 13684292
SIC: 2834 Pharmaceutical Preparations